Skip to main content Back to Top
Advertisement

7/27/2022

Amphetamine Mixed Salts, Immediate-Release Tablets

Products Affected - Description

    • Adderall immediate release tablet, Teva, 20 mg, bottle, 100 count, NDC 57844-0120-01
    • Adderall immediate release tablet, Teva, 30 mg, bottle, 100 count, NDC 57844-0130-01
    • Amphetamine mixed salts immediate release tablet, Teva, 10 mg, bottle, 100 count, NDC 00555-0972-02
    • Amphetamine mixed salts immediate release tablet, Teva, 15 mg, bottle, 100 count, NDC 00555-0777-02
    • Amphetamine mixed salts immediate release tablet, Teva, 20 mg, bottle, 100 count, NDC 00555-0973-02
    • Amphetamine mixed salts immediate release tablet, Teva, 30 mg, bottle, 100 count, NDC 00555-0974-02

Reason for the Shortage

    • Aurobindo refuses to provide availability information.
    • Mallincrodt availability information is forthcoming.
    • Teva did not provide a reason for the shortage.
    • Mylan and Zydus have discontinued amphetamine mixed salt tablets.

Available Products

    • Adderall immediate release tablet, Teva, 10 mg, bottle, 100 count, NDC 57844-0110-01
    • Adderall immediate release tablet, Teva, 12.5 mg, bottle, 100 count, NDC 57844-0112-01
    • Adderall immediate release tablet, Teva, 15 mg, bottle, 100 count, NDC 57844-0115-01
    • Adderall immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 57844-0105-01
    • Adderall immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 57844-0117-01
    • Amphetamine mixed salts immediate release tablet, Teva, 12.5 mg, bottle, 100 count, NDC 00555-0776-02
    • Amphetamine mixed salts immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 00555-0971-02
    • Amphetamine mixed salts immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 00555-0775-02 - discontinued

Estimated Resupply Dates

    • Teva has Adderall 20 mg and 30 mg tablets on back order and the company estimates a release date in early- to mid-August 2022.
    • Teva has amphetamine mixed salts in 10 mg, 15 mg, 20 mg, and 30 mg tablets on back order and the company estimates release dates in early- to mid-August 2022 for the 10 mg tablets, mid-August 2022 for the 15 mg and 30 mg tablets, and late-August 2022 for the 20 mg tablets.

Updated

Created July 27, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.